References
References - curated
Region Position Markers
QTLs in Region (GRCh38)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 407025473 | GWAS674449_H | high density lipoprotein cholesterol measurement QTL GWAS674449 (human) | 3e-96 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406960711 | GWAS609687_H | high density lipoprotein cholesterol measurement QTL GWAS609687 (human) | 1e-213 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407077194 | GWAS726170_H | phospholipids:total lipids ratio QTL GWAS726170 (human) | 3e-152 | phospholipids:total lipids ratio | 15 | 58391167 | 58391168 | Human | 407097418 | GWAS746394_H | phospholipids:total lipids ratio QTL GWAS746394 (human) | 2e-107 | phospholipids:total lipids ratio | 15 | 58391167 | 58391168 | Human | 407293516 | GWAS942492_H | phosphatidylethanolamine measurement QTL GWAS942492 (human) | 4e-13 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406984521 | GWAS633497_H | high density lipoprotein cholesterol measurement QTL GWAS633497 (human) | 9e-25 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407256909 | GWAS905885_H | fatty acid measurement QTL GWAS905885 (human) | 3e-99 | fatty acid measurement | 15 | 58391167 | 58391168 | Human | 407052367 | GWAS701343_H | total cholesterol measurement QTL GWAS701343 (human) | 7e-47 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58391167 | 58391168 | Human | 407291979 | GWAS940955_H | phosphatidylethanolamine measurement QTL GWAS940955 (human) | 3e-34 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58391167 | 58391168 | Human | 406945102 | GWAS594078_H | protein measurement QTL GWAS594078 (human) | 7e-23 | protein measurement | 15 | 58391167 | 58391168 | Human | 407058508 | GWAS707484_H | serum metabolite measurement QTL GWAS707484 (human) | 3e-14 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 2299958 | PRSTS330_H | Prostate tumor susceptibility QTL 330 (human) | 1.02 | 0.0151 | Prostate tumor susceptibility | 15 | 34790230 | 60790230 | Human | 407021399 | GWAS670375_H | high density lipoprotein cholesterol measurement QTL GWAS670375 (human) | 1e-35 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407339870 | GWAS988846_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio QTL GWAS988846 (human) | 7e-113 | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58391167 | 58391168 | Human | 406927707 | GWAS576683_H | serum metabolite measurement QTL GWAS576683 (human) | 2e-15 | glycerophospholipid measurement | 15 | 58391167 | 58391168 | Human | 407098975 | GWAS747951_H | triglyceride measurement QTL GWAS747951 (human) | 2e-19 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 407242330 | GWAS891306_H | phosphatidylethanolamine measurement QTL GWAS891306 (human) | 5e-47 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407266650 | GWAS915626_H | high density lipoprotein cholesterol measurement QTL GWAS915626 (human) | 6e-25 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407098974 | GWAS747950_H | triglyceride measurement QTL GWAS747950 (human) | 8e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 406935391 | GWAS584367_H | serum metabolite measurement QTL GWAS584367 (human) | 3e-16 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406927710 | GWAS576686_H | serum metabolite measurement QTL GWAS576686 (human) | 7e-15 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407256678 | GWAS905654_H | fatty acid measurement QTL GWAS905654 (human) | 3e-82 | fatty acid measurement | 15 | 58391167 | 58391168 | Human | 407330150 | GWAS979126_H | triglyceride measurement QTL GWAS979126 (human) | 7e-18 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 406935395 | GWAS584371_H | serum metabolite measurement QTL GWAS584371 (human) | 9e-32 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407010663 | GWAS659639_H | hemoglobin measurement QTL GWAS659639 (human) | 4e-15 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 15 | 58391167 | 58391168 | Human | 1559354 | LDLPS4_H | Low density lipoprotein particle size QTL 4 (human) | 2.2 | 0.019 | LDL particle size | 15 | 34790230 | 60790230 | Human | 407073646 | GWAS722622_H | complex trait QTL GWAS722622 (human) | 4e-44 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407319657 | GWAS968633_H | glycerophospholipid measurement QTL GWAS968633 (human) | 4e-20 | glycerophospholipid measurement | 15 | 58391167 | 58391168 | Human | 407025261 | GWAS674237_H | total cholesterol measurement QTL GWAS674237 (human) | 9e-20 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58391167 | 58391168 | Human | 407036269 | GWAS685245_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS685245 (human) | 8e-41 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406916976 | GWAS565952_H | low density lipoprotein cholesterol measurement QTL GWAS565952 (human) | 9e-16 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 15 | 58391167 | 58391168 | Human | 407024496 | GWAS673472_H | cholesterol to total lipids in large LDL percentage QTL GWAS673472 (human) | 6e-87 | cholesterol to total lipids in large LDL percentage | 15 | 58391167 | 58391168 | Human | 406931058 | GWAS580034_H | serum metabolite measurement QTL GWAS580034 (human) | 6e-74 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406925172 | GWAS574148_H | serum metabolite measurement QTL GWAS574148 (human) | 5e-32 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406950007 | GWAS598983_H | lipid measurement QTL GWAS598983 (human) | 9e-15 | lipid measurement | blood lipid measurement (CMO:0000050) | 15 | 58391167 | 58391168 | Human | 407133298 | GWAS782274_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS782274 (human) | 3e-244 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406950006 | GWAS598982_H | lipid measurement QTL GWAS598982 (human) | 1e-19 | lipid measurement | blood lipid measurement (CMO:0000050) | 15 | 58391167 | 58391168 | Human | 406931064 | GWAS580040_H | serum metabolite measurement QTL GWAS580040 (human) | 4e-47 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407169151 | GWAS818127_H | phosphatidylethanolamine measurement QTL GWAS818127 (human) | 6e-20 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406931071 | GWAS580047_H | serum metabolite measurement QTL GWAS580047 (human) | 3e-19 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406925182 | GWAS574158_H | serum metabolite measurement QTL GWAS574158 (human) | 1e-50 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407316856 | GWAS965832_H | glycerophospholipid measurement QTL GWAS965832 (human) | 3e-18 | glycerophospholipid measurement | 15 | 58391167 | 58391168 | Human | 406920704 | GWAS569680_H | total cholesterol measurement QTL GWAS569680 (human) | 2e-40 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58391167 | 58391168 | Human | 407321092 | GWAS970068_H | glycerophospholipid measurement QTL GWAS970068 (human) | 7e-16 | glycerophospholipid measurement | 15 | 58391167 | 58391168 | Human | 407308803 | GWAS957779_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio QTL GWAS957779 (human) | 8e-81 | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58391167 | 58391168 | Human | 407321091 | GWAS970067_H | glycerophospholipid measurement QTL GWAS970067 (human) | 1e-26 | glycerophospholipid measurement | 15 | 58391167 | 58391168 | Human | 406907397 | GWAS556373_H | high density lipoprotein cholesterol measurement QTL GWAS556373 (human) | 4e-98 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406907398 | GWAS556374_H | high density lipoprotein cholesterol measurement QTL GWAS556374 (human) | 0.000007 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407094277 | GWAS743253_H | cholesteryl esters to total lipids in large HDL percentage QTL GWAS743253 (human) | 8e-16 | cholesteryl esters to total lipids in large HDL percentage | 15 | 58391167 | 58391168 | Human | 406907399 | GWAS556375_H | high density lipoprotein cholesterol measurement QTL GWAS556375 (human) | 2e-12 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406907400 | GWAS556376_H | high density lipoprotein cholesterol measurement QTL GWAS556376 (human) | 0.000004 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406907401 | GWAS556377_H | high density lipoprotein cholesterol measurement QTL GWAS556377 (human) | 2e-116 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407192073 | GWAS841049_H | phosphatidylcholine measurement QTL GWAS841049 (human) | 4e-106 | phosphatidylcholine measurement | 15 | 58391167 | 58391168 | Human | 407094541 | GWAS743517_H | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement QTL GWAS743517 (human) | 4e-115 | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement | 15 | 58391167 | 58391168 | Human | 407076114 | GWAS725090_H | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage QTL GWAS725090 (human) | 3e-66 | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 15 | 58391167 | 58391168 | Human | 407057431 | GWAS706407_H | serum metabolite measurement QTL GWAS706407 (human) | 0.0000001 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407183889 | GWAS832865_H | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio QTL GWAS832865 (human) | 2e-168 | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58391167 | 58391168 | Human | 407328785 | GWAS977761_H | very low density lipoprotein cholesterol measurement QTL GWAS977761 (human) | 2e-78 | very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58391167 | 58391168 | Human | 407085339 | GWAS734315_H | high density lipoprotein cholesterol measurement QTL GWAS734315 (human) | 0.000008 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406923544 | GWAS572520_H | serum metabolite measurement QTL GWAS572520 (human) | 2e-08 | level of Phosphatidylcholine (O-16:1_18:1) in blood serum | 15 | 58391167 | 58391168 | Human | 407096093 | GWAS745069_H | free cholesterol to total lipids in large VLDL percentage QTL GWAS745069 (human) | 2e-79 | free cholesterol to total lipids in large VLDL percentage | 15 | 58391167 | 58391168 | Human | 407193115 | GWAS842091_H | phosphatidylcholine measurement QTL GWAS842091 (human) | 6e-112 | phosphatidylcholine measurement | 15 | 58391167 | 58391168 | Human | 406935329 | GWAS584305_H | serum metabolite measurement QTL GWAS584305 (human) | 2e-13 | serum metabolite measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 407057443 | GWAS706419_H | serum metabolite measurement QTL GWAS706419 (human) | 0.0000002 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407202343 | GWAS851319_H | phosphatidylcholine measurement QTL GWAS851319 (human) | 1e-39 | phosphatidylcholine measurement | 15 | 58391167 | 58391168 | Human | 407098663 | GWAS747639_H | total cholesterol measurement QTL GWAS747639 (human) | 2e-20 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58391167 | 58391168 | Human | 407168032 | GWAS817008_H | phosphatidylcholine measurement QTL GWAS817008 (human) | 3e-12 | phosphatidylcholine measurement | 15 | 58391167 | 58391168 | Human | 407051562 | GWAS700538_H | metabolic syndrome QTL GWAS700538 (human) | 5e-24 | metabolic syndrome | 15 | 58391167 | 58391168 | Human | 407191086 | GWAS840062_H | phosphatidylcholine measurement QTL GWAS840062 (human) | 5e-75 | phosphatidylcholine measurement | 15 | 58391167 | 58391168 | Human | 407291691 | GWAS940667_H | phosphatidylethanolamine measurement QTL GWAS940667 (human) | 1e-47 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407076141 | GWAS725117_H | phospholipids:total lipids ratio QTL GWAS725117 (human) | 3e-55 | phospholipids:total lipids ratio | 15 | 58391167 | 58391168 | Human | 407168555 | GWAS817531_H | phosphatidylethanolamine measurement QTL GWAS817531 (human) | 3e-15 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407086387 | GWAS735363_H | 1-arachidonoyl-GPE (20:4n6) measurement QTL GWAS735363 (human) | 5e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 406932528 | GWAS581504_H | serum metabolite measurement QTL GWAS581504 (human) | 6e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407246135 | GWAS895111_H | phosphatidylcholine measurement QTL GWAS895111 (human) | 7e-93 | phosphatidylcholine measurement | 15 | 58391167 | 58391168 | Human | 406915893 | GWAS564869_H | triglyceride measurement QTL GWAS564869 (human) | 9e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 407037750 | GWAS686726_H | saturated fatty acids to total fatty acids percentage QTL GWAS686726 (human) | 3e-25 | saturated fatty acids to total fatty acids percentage | 15 | 58391167 | 58391168 | Human | 407074615 | GWAS723591_H | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage QTL GWAS723591 (human) | 8e-91 | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 15 | 58391167 | 58391168 | Human | 407076662 | GWAS725638_H | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage QTL GWAS725638 (human) | 1e-114 | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 15 | 58391167 | 58391168 | Human | 407332414 | GWAS981390_H | phosphatidylethanolamine measurement QTL GWAS981390 (human) | 2e-82 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407127609 | GWAS776585_H | complex trait QTL GWAS776585 (human) | 2e-39 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406925761 | GWAS574737_H | serum metabolite measurement QTL GWAS574737 (human) | 3e-09 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407036610 | GWAS685586_H | level of Phosphatidylcholine (16:0_18:1) in blood serum QTL GWAS685586 (human) | 6e-09 | level of Phosphatidylcholine (16:0_16:0) in blood serum | 15 | 58391167 | 58391168 | Human | 407267527 | GWAS916503_H | C-reactive protein measurement QTL GWAS916503 (human) | 5e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 15 | 58391167 | 58391168 | Human | 407318726 | GWAS967702_H | phosphatidylethanolamine measurement QTL GWAS967702 (human) | 3e-30 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407098817 | GWAS747793_H | total cholesterol measurement QTL GWAS747793 (human) | 2e-27 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58391167 | 58391168 | Human | 407166150 | GWAS815126_H | phosphatidylethanolamine measurement QTL GWAS815126 (human) | 7e-24 | blood phospholipid amount (VT:0006084) | 15 | 58391167 | 58391168 | Human | 407308228 | GWAS957204_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS957204 (human) | 2e-144 | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58391167 | 58391168 | Human | 406950087 | GWAS599063_H | hemoglobin measurement QTL GWAS599063 (human) | 7e-11 | level of Phosphatidylcholine (18:1_18:1) in blood serum | hemoglobin measurement (CMO:0000508) | 15 | 58391167 | 58391168 | Human | 407170498 | GWAS819474_H | diglyceride measurement QTL GWAS819474 (human) | 7e-21 | diglyceride measurement | 15 | 58391167 | 58391168 | Human | 407318732 | GWAS967708_H | phosphatidylethanolamine measurement QTL GWAS967708 (human) | 1e-18 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407308492 | GWAS957468_H | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement QTL GWAS957468 (human) | 2e-155 | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58391167 | 58391168 | Human | 407316170 | GWAS965146_H | glycerophospholipid measurement QTL GWAS965146 (human) | 9e-27 | glycerophospholipid measurement | 15 | 58391167 | 58391168 | Human | 407318998 | GWAS967974_H | phosphatidylethanolamine measurement QTL GWAS967974 (human) | 2e-41 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406923474 | GWAS572450_H | serum metabolite measurement QTL GWAS572450 (human) | 7e-09 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407115216 | GWAS764192_H | high density lipoprotein cholesterol measurement QTL GWAS764192 (human) | 1e-65 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407175889 | GWAS824865_H | phosphatidylethanolamine measurement QTL GWAS824865 (human) | 3e-27 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406928852 | GWAS577828_H | 2-stearoyl-GPE (18:0) measurement QTL GWAS577828 (human) | 9e-18 | 2-stearoyl-GPE (18:0) measurement | 15 | 58391167 | 58391168 | Human | 406923483 | GWAS572459_H | serum metabolite measurement QTL GWAS572459 (human) | 1e-08 | vitamin D deficiency | 15 | 58391167 | 58391168 | Human | 407056601 | GWAS705577_H | level of phosphatidylcholine QTL GWAS705577 (human) | 4e-11 | level of phosphatidylcholine | 15 | 58391167 | 58391168 | Human | 406928605 | GWAS577581_H | serum metabolite measurement QTL GWAS577581 (human) | 9e-45 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407211224 | GWAS860200_H | lipoprotein A measurement QTL GWAS860200 (human) | 9e-10 | lipoprotein A measurement | 15 | 58391167 | 58391168 | Human | 406928607 | GWAS577583_H | serum metabolite measurement QTL GWAS577583 (human) | 5e-50 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407024348 | GWAS673324_H | cholesteryl esters to total lipids in large LDL percentage QTL GWAS673324 (human) | 1e-54 | cholesteryl esters to total lipids in large LDL percentage | 15 | 58391167 | 58391168 | Human | 407319000 | GWAS967976_H | phosphatidylethanolamine measurement QTL GWAS967976 (human) | 7e-45 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406928609 | GWAS577585_H | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement QTL GWAS577585 (human) | 2e-55 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 15 | 58391167 | 58391168 | Human | 406931169 | GWAS580145_H | serum metabolite measurement QTL GWAS580145 (human) | 1e-10 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407038434 | GWAS687410_H | level of Sphingomyelin (d34:2) in blood serum QTL GWAS687410 (human) | 8e-11 | level of Sphingomyelin (d34:2) in blood serum | 15 | 58391167 | 58391168 | Human | 407175908 | GWAS824884_H | phosphatidylethanolamine measurement QTL GWAS824884 (human) | 9e-100 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406932453 | GWAS581429_H | serum metabolite measurement QTL GWAS581429 (human) | 5e-46 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407321313 | GWAS970289_H | phosphatidylethanolamine measurement QTL GWAS970289 (human) | 1e-41 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407241711 | GWAS890687_H | docosahexaenoic acid measurement, fatty acid measurement QTL GWAS890687 (human) | 1e-45 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 15 | 58391167 | 58391168 | Human | 407321068 | GWAS970044_H | phosphatidylethanolamine measurement QTL GWAS970044 (human) | 8e-42 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407321065 | GWAS970041_H | phosphatidylethanolamine measurement QTL GWAS970041 (human) | 4e-41 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406935536 | GWAS584512_H | serum metabolite measurement QTL GWAS584512 (human) | 2e-18 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 406927604 | GWAS576580_H | serum metabolite measurement QTL GWAS576580 (human) | 3e-29 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406930935 | GWAS579911_H | serum metabolite measurement QTL GWAS579911 (human) | 2e-33 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407050229 | GWAS699205_H | lysophosphatidylethanolamine 16:0 measurement QTL GWAS699205 (human) | 4e-12 | blood lipid amount (VT:0003949) | 15 | 58391167 | 58391168 | Human | 407278847 | GWAS927823_H | triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS927823 (human) | 9e-155 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407074041 | GWAS723017_H | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage QTL GWAS723017 (human) | 2e-124 | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 15 | 58391167 | 58391168 | Human | 406930943 | GWAS579919_H | serum metabolite measurement QTL GWAS579919 (human) | 5e-23 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406928894 | GWAS577870_H | sleep duration, high density lipoprotein cholesterol measurement QTL GWAS577870 (human) | 2e-83 | sleep duration, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406927614 | GWAS576590_H | serum metabolite measurement QTL GWAS576590 (human) | 6e-19 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406925185 | GWAS574161_H | serum metabolite measurement QTL GWAS574161 (human) | 1e-58 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407182983 | GWAS831959_H | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio QTL GWAS831959 (human) | 9e-171 | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58391167 | 58391168 | Human | 406925186 | GWAS574162_H | serum metabolite measurement QTL GWAS574162 (human) | 2e-49 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406924421 | GWAS573397_H | serum metabolite measurement QTL GWAS573397 (human) | 1e-36 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406926724 | GWAS575700_H | serum metabolite measurement QTL GWAS575700 (human) | 2e-10 | 1-stearoyl-GPG (18:0) measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406932361 | GWAS581337_H | serum metabolite measurement QTL GWAS581337 (human) | 4e-18 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406924425 | GWAS573401_H | serum metabolite measurement QTL GWAS573401 (human) | 3e-48 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406923404 | GWAS572380_H | serum metabolite measurement QTL GWAS572380 (human) | 4e-09 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407054734 | GWAS703710_H | HDL cholesterol change measurement QTL GWAS703710 (human) | 6e-16 | HDL cholesterol change measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 406932366 | GWAS581342_H | serum metabolite measurement QTL GWAS581342 (human) | 4e-16 | lipid measurement | blood lipid measurement (CMO:0000050) | 15 | 58391167 | 58391168 | Human | 406924430 | GWAS573406_H | serum metabolite measurement QTL GWAS573406 (human) | 1e-21 | cholesteryl esters to total lipids in very small VLDL percentage | 15 | 58391167 | 58391168 | Human | 406934417 | GWAS583393_H | serum metabolite measurement QTL GWAS583393 (human) | 8e-12 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 407042194 | GWAS691170_H | level of Phosphatidylcholine (O-16:1_18:2) in blood serum QTL GWAS691170 (human) | 9e-12 | level of Phosphatidylcholine (O-16:1_18:2) in blood serum | 15 | 58391167 | 58391168 | Human | 407059858 | GWAS708834_H | serum metabolite measurement QTL GWAS708834 (human) | 4e-32 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407059857 | GWAS708833_H | serum metabolite measurement QTL GWAS708833 (human) | 3e-42 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407096465 | GWAS745441_H | cholesteryl esters to total lipids in large VLDL percentage QTL GWAS745441 (human) | 5e-133 | cholesteryl esters to total lipids in large VLDL percentage | 15 | 58391167 | 58391168 | Human | 407051415 | GWAS700391_H | high density lipoprotein cholesterol measurement QTL GWAS700391 (human) | 1e-188 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58391167 | 58391168 | Human | 407059863 | GWAS708839_H | serum metabolite measurement QTL GWAS708839 (human) | 2e-24 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407059862 | GWAS708838_H | serum metabolite measurement QTL GWAS708838 (human) | 4e-25 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406928535 | GWAS577511_H | serum metabolite measurement QTL GWAS577511 (human) | 1e-09 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406928534 | GWAS577510_H | serum metabolite measurement QTL GWAS577510 (human) | 1e-13 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407164819 | GWAS813795_H | phosphatidylethanolamine measurement QTL GWAS813795 (human) | 6e-24 | phosphatidylcholine measurement | 15 | 58391167 | 58391168 | Human | 407061400 | GWAS710376_H | serum metabolite measurement QTL GWAS710376 (human) | 0.000005 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406926236 | GWAS575212_H | serum metabolite measurement QTL GWAS575212 (human) | 4e-08 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407059870 | GWAS708846_H | serum metabolite measurement QTL GWAS708846 (human) | 2e-22 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407024285 | GWAS673261_H | cholesterol to total lipids in large VLDL percentage QTL GWAS673261 (human) | 1e-132 | cholesterol to total lipids in large VLDL percentage | 15 | 58391167 | 58391168 | Human | 407059868 | GWAS708844_H | serum metabolite measurement QTL GWAS708844 (human) | 3e-23 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407058850 | GWAS707826_H | serum metabolite measurement QTL GWAS707826 (human) | 7e-13 | 1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)* measurement | 15 | 58391167 | 58391168 | Human | 407023520 | GWAS672496_H | free cholesterol to total lipids in very large VLDL percentage QTL GWAS672496 (human) | 3e-73 | free cholesterol to total lipids in very large VLDL percentage | 15 | 58391167 | 58391168 | Human | 406928549 | GWAS577525_H | serum metabolite measurement QTL GWAS577525 (human) | 3e-11 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406928551 | GWAS577527_H | serum metabolite measurement QTL GWAS577527 (human) | 1e-12 | lysophosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406896296 | GWAS545272_H | 1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2) measurement QTL GWAS545272 (human) | 7e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58391167 | 58391168 | Human | 407092138 | GWAS741114_H | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement QTL GWAS741114 (human) | 3e-116 | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement | 15 | 58391167 | 58391168 | Human | 407021224 | GWAS670200_H | total cholesterol measurement QTL GWAS670200 (human) | 0.0000004 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58391167 | 58391168 | Human | 406927793 | GWAS576769_H | serum metabolite measurement QTL GWAS576769 (human) | 7e-17 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 406924209 | GWAS573185_H | serum metabolite measurement QTL GWAS573185 (human) | 0.000002 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407039154 | GWAS688130_H | coronary artery calcification QTL GWAS688130 (human) | 9e-104 | coronary artery calcification | 15 | 58391167 | 58391168 | Human | 407024048 | GWAS673024_H | triglycerides to total lipids in very large VLDL percentage QTL GWAS673024 (human) | 3e-38 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 407091888 | GWAS740864_H | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement QTL GWAS740864 (human) | 1e-145 | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement | 15 | 58391167 | 58391168 | Human | 407059383 | GWAS708359_H | C-reactive protein measurement QTL GWAS708359 (human) | 3e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 15 | 58391167 | 58391168 | Human | 407327935 | GWAS976911_H | fatty acid measurement QTL GWAS976911 (human) | 4e-22 | fatty acid measurement | 15 | 58391167 | 58391168 | Human | 407038395 | GWAS687371_H | level of phosphatidylcholine QTL GWAS687371 (human) | 1e-23 | level of phosphatidylcholine | 15 | 58391167 | 58391168 | Human | 406917306 | GWAS566282_H | triglyceride measurement QTL GWAS566282 (human) | 3e-51 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58391167 | 58391168 | Human | 407169983 | GWAS818959_H | phosphatidylethanolamine measurement QTL GWAS818959 (human) | 9e-86 | phosphatidylethanolamine measurement | 15 | 58391167 | 58391168 | Human | 406929343 | GWAS578319_H | serum metabolite measurement QTL GWAS578319 (human) | 2e-42 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | 407143610 | GWAS792586_H | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement QTL GWAS792586 (human) | 6e-61 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58391167 | 58391168 | Human | 406927806 | GWAS576782_H | serum metabolite measurement QTL GWAS576782 (human) | 7e-61 | serum metabolite measurement | 15 | 58391167 | 58391168 | Human | |
Additional Information
GWAS QTLs Related by Peak Marker
Data has come from the GWAS Catalog | ||
The highlighted row represents the current QTL |
QTL | GWAS Catalog Study | Disease Trait | Study Size | Risk Allele | Risk Allele Frequency | P Value | P Value MLOG | Peak Marker | Reported Odds Ratio or Beta-coefficient | Ontology Accession | PubMed |
GWAS545272_H | GCST90244959 | 1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2) levels | 14,296 European ancestry individuals | A | 0.3873 | 7E-10 | 9.155 | rs1532085 | 0.06434421 | 1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2) measurement (EFO:0800430) |
PMID:36357675 |
GWAS556373_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | 0.378 | 4E-98 | 97.398 | rs1532085 | 0.081 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS556374_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | 0.376 | 0.000007 | 5.155 | rs1532085 | 0.057 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS556375_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | 0.49 | 2E-12 | 11.699 | rs1532085 | 0.093 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS556376_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | 0.52 | 0.000004 | 5.398 | rs1532085 | 0.098 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS556377_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | NR | 2E-116 | 115.699 | rs1532085 | 0.08 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS564869_H | GCST008702 | Triglyceride levels | up to 23,508 African ancestry individuals, 4,649 Asian ancestry individuals, up to 77,047 European ancestry individuals, 6,705 Hispanic individuals | A | 0.4038 | 9E-8 | 7.046 | rs1532085 | 0.013 | triglyceride measurement (EFO:0004530) |
PMID:30926973 |
GWAS565952_H | GCST010245 | LDL cholesterol levels | 440,546 European ancestry individuals | A | 0.386409 | 9E-16 | 15.046 | rs1532085 | 0.017242 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:32203549 |
GWAS566282_H | GCST010244 | Triglyceride levels | 441,016 European ancestry individuals | A | 0.386452 | 3E-51 | 50.523 | rs1532085 | 0.0308141 | triglyceride measurement (EFO:0004530) |
PMID:32203549 |
GWAS569680_H | GCST90278644 | Total cholesterol levels | 92,615 Taiwanese ancestry individuals | ? | NR | 2E-40 | 39.699 | rs1532085 | N/A | total cholesterol measurement (EFO:0004574) |
PMID:38116116 |
GWAS572380_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 4E-9 | 8.398 | rs1532085 | 0.08684096 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS572450_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 7E-9 | 8.155 | rs1532085 | 0.0853106 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS572459_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 1E-8 | 8 | rs1532085 | 0.0835205 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS572520_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-8 | 7.699 | rs1532085 | 0.08348236 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS573185_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 0.000002 | 5.699 | rs1532085 | 0.069876485 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS573397_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-36 | 36 | rs1532085 | 0.11400284 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS573401_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 3E-48 | 47.523 | rs1532085 | 0.10953996 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS573406_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-21 | 21 | rs1532085 | 0.08734269 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS574148_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 5E-32 | 31.302 | rs1532085 | 0.09050984 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS574158_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-50 | 50 | rs1532085 | 0.1423958 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS574161_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-58 | 58 | rs1532085 | 0.13074026 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS574162_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-49 | 48.699 | rs1532085 | 0.15250725 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS574737_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 3E-9 | 8.523 | rs1532085 | 0.074650936 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS575212_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 4E-8 | 7.398 | rs1532085 | 0.081478536 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS575700_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-10 | 9.699 | rs1532085 | 0.09398883 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS576580_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 3E-29 | 28.523 | rs1532085 | 0.054096222 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS576590_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 6E-19 | 18.222 | rs1532085 | 0.060541064 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS576683_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-15 | 14.699 | rs1532085 | 0.11655516 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS576686_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 7E-15 | 14.155 | rs1532085 | 0.11560253 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS576769_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 7E-17 | 16.155 | rs1532085 | 0.1229284 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS576782_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 7E-61 | 60.155 | rs1532085 | 0.20530656 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS577510_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-13 | 13 | rs1532085 | 0.049979195 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS577511_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-9 | 9 | rs1532085 | 0.04766495 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
None Available | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-10 | 9.699 | rs1532085 | 0.055791527 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS577525_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 3E-11 | 10.523 | rs1532085 | 0.062062085 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS577527_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-12 | 12 | rs1532085 | 0.06319349 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS577581_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 9E-45 | 44.046 | rs1532085 | 0.14934805 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS577583_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 5E-50 | 49.302 | rs1532085 | 0.11360955 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS577585_H | GCST90102725 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) levels | 8,809 European ancestry individuals | A | NR | 2E-55 | 54.699 | rs1532085 | 0.238 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement (EFO:0800608) |
PMID:35050183 |
None Available | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-15 | 14.699 | rs1532085 | 0.10680944 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS577828_H | GCST90102790 | 2-stearoyl-GPE (18:0) levels | 8,809 European ancestry individuals | A | NR | 9E-18 | 17.046 | rs1532085 | 0.132 | 2-stearoyl-GPE (18:0) measurement (EFO:0800343) |
PMID:35050183 |
GWAS577870_H | GCST009367 | HDL cholesterol levels x short total sleep time interaction (2df test) | 3,007 African American short sleepers, 369 Chinese ancestry short sleepers, 114 Asian ancestry short sleepers, at least 8,474 European ancestry short sleepers, 1,082 Hispanic/Latino short sleepers, up to 11,901 African American controls, 1,444 Chinese ancestry controls, 452 Asian ancestry controls, at least 31,567 European ancestry controls, 4,047 Hispanic/Latino controls | ? | NR | 2E-83 | 82.699 | rs1532085 | 0.01819 | sleep duration (EFO:0005271) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:31719535 |
GWAS578319_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-42 | 41.699 | rs1532085 | 0.06431696 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS579911_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-33 | 32.699 | rs1532085 | 0.08897158 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS579919_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 5E-23 | 22.302 | rs1532085 | 0.0951767 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS580034_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 6E-74 | 73.222 | rs1532085 | 0.1949246 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS580040_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 4E-47 | 46.398 | rs1532085 | 0.16946794 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS580047_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 3E-19 | 18.523 | rs1532085 | 0.084320836 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS580145_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-10 | 10 | rs1532085 | 0.0629485 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
None Available | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-15 | 14.699 | rs1532085 | 0.07249342 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS581337_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 4E-18 | 17.398 | rs1532085 | 0.076837495 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS581342_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 4E-16 | 15.398 | rs1532085 | 0.06878999 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS581429_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 5E-46 | 45.302 | rs1532085 | 0.095103495 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS581504_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 6E-11 | 10.222 | rs1532085 | 0.07166508 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS583393_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 8E-12 | 11.097 | rs1532085 | 0.07904208 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS584305_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-13 | 12.699 | rs1532085 | 0.07723854 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS584367_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 3E-16 | 15.523 | rs1532085 | 0.107279025 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS584371_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 9E-32 | 31.046 | rs1532085 | 0.1045856 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS584512_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-18 | 17.699 | rs1532085 | 0.116394006 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS594078_H | GCST90250219 | Protein Wnt-5a levels | 10,708 European ancestry individuals | A | 0.38 | 7E-23 | 22.155 | rs1532085 | 0.134 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS598982_H | GCST000533 | Lipid metabolism phenotypes | Up to 17,296 European ancestry female individuals | ? | NR | 1E-19 | 19 | rs1532085 | 0.107 | lipid measurement (EFO:0004529) |
PMID:19936222 |
None Available | GCST000533 | Lipid metabolism phenotypes | Up to 17,296 European ancestry female individuals | ? | NR | 4E-16 | 15.398 | rs1532085 | 0.112 | lipid measurement (EFO:0004529) |
PMID:19936222 |
GWAS598983_H | GCST000533 | Lipid metabolism phenotypes | Up to 17,296 European ancestry female individuals | ? | NR | 9E-15 | 14.046 | rs1532085 | 1.421 | lipid measurement (EFO:0004529) |
PMID:19936222 |
GWAS599063_H | GCST001765 | Red blood cell traits | 62,553 European ancestry individuals, 9,308 South Asian ancestry individuals | G | 0.59 | 7E-11 | 10.155 | rs1532085 | 0.034 | hemoglobin measurement (EFO:0004509) |
PMID:23222517 |
None Available | GCST90249453 | Sodium-coupled monocarboxylate transporter 1 levels | 10,708 European ancestry individuals | A | 0.38 | 8E-12 | 11.097 | rs1532085 | 0.094 | sodium-coupled monocarboxylate transporter 1 measurement (EFO:0802076) |
PMID:34648354 |
GWAS609687_H | GCST004232 | HDL cholesterol levels | 34,930 East Asian ancestry individuals, 187,167 European ancestry individuals | A | 0.367 | 1E-213 | 213 | rs1532085 | 0.107 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:28334899 |
GWAS633497_H | GCST008035 | High density lipoprotein cholesterol levels | 10,085 African American individuals, 17,751 Hispanic/Latino individuals, 2,378 Asian ancestry individuals, 1,912 Native Hawaiian ancestry individuals, 604 Native American ancestry individuals, 333 individuals | ? | NR | 9E-25 | 24.046 | rs1532085 | 1.156662 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:31217584 |
GWAS659639_H | GCST010083 | Hemoglobin levels | 684,122 European ancestry individuals | A | NR | 4E-15 | 14.398 | rs1532085 | 0.017 | hemoglobin measurement (EFO:0004509) |
PMID:32327693 |
None Available | GCST000284 | HDL cholesterol | 4,763 Northern Finnish founder individuals | A | 0.44 | 2E-10 | 9.699 | rs1532085 | 0.05 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:19060910 |
GWAS670200_H | GCST000285 | Cholesterol, total | 21,848 European ancestry individuals, 714 Orcadian individuals | G | 0.59 | 4E-7 | 6.398 | rs1532085 | 0.05 | total cholesterol measurement (EFO:0004574) |
PMID:19060911 |
GWAS670375_H | GCST000288 | HDL cholesterol | 20,697 European ancestry individuals, 715 Orcadian individuals | G | 0.59 | 1E-35 | 35 | rs1532085 | 0.13 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:19060911 |
GWAS672496_H | GCST90269684 | Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587) | 87,620 European ancestry individuals | A | 0.385682 | 3E-73 | 72.523 | rs1532085 | 0.0852069 | free cholesterol to total lipids in very large VLDL percentage (EFO:0022289) |
PMID:36764567 |
GWAS673024_H | GCST90269685 | Triglycerides to total lipids in very large VLDL percentage (UKB data field 23588) | 87,620 European ancestry individuals | A | 0.385682 | 3E-38 | 37.523 | rs1532085 | 0.0609493 | triglycerides to total lipids in very large VLDL percentage (EFO:0022340) |
PMID:36764567 |
GWAS673261_H | GCST90269687 | Cholesterol to total lipids in large VLDL percentage (UKB data field 23590) | 88,321 European ancestry individuals | A | 0.386012 | 1E-132 | 132 | rs1532085 | 0.116471 | cholesterol to total lipids in large VLDL percentage (EFO:0022236) |
PMID:36764567 |
GWAS673324_H | GCST90269713 | Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616) | 88,329 European ancestry individuals | A | 0.386011 | 1E-54 | 54 | rs1532085 | 0.0752546 | cholesteryl esters to total lipids in large LDL percentage (EFO:0022249) |
PMID:36764567 |
GWAS673472_H | GCST90269712 | Cholesterol to total lipids in large LDL percentage (UKB data field 23615) | 88,329 European ancestry individuals | A | 0.386011 | 6E-87 | 86.222 | rs1532085 | 0.093238 | cholesterol to total lipids in large LDL percentage (EFO:0022235) |
PMID:36764567 |
None Available | GCST90269703 | Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606) | 88,329 European ancestry individuals | A | 0.386011 | 1E-21 | 21 | rs1532085 | 0.0439818 | cholesteryl esters to total lipids in very small VLDL percentage (EFO:0022259) |
PMID:36764567 |
None Available | GCST000758 | Triglycerides | 96,598 European ancestry individuals | G | 0.22 | 2E-13 | 12.699 | rs1532085 | 2.99 | triglyceride measurement (EFO:0004530) |
PMID:20686565 |
GWAS674237_H | GCST000760 | Cholesterol, total | 100,184 European ancestry individuals | A | 0.39 | 9E-20 | 19.046 | rs1532085 | 1.54 | total cholesterol measurement (EFO:0004574) |
PMID:20686565 |
GWAS674449_H | GCST000755 | HDL cholesterol | 99,900 European ancestry individuals | A | 0.39 | 3E-96 | 95.523 | rs1532085 | 1.45 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:20686565 |
None Available | GCST90277308 | Phosphatidylcholine (18:1_18:1) levels | 7,174 Finnish ancestry individuals | A | 0.426559 | 7E-11 | 10.155 | rs1532085 | 0.109594 | PMID:37907536 | |
GWAS685245_H | GCST90269549 | Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452) | 88,268 European ancestry individuals | A | 0.38604 | 8E-41 | 40.097 | rs1532085 | 0.0624332 | omega-6 polyunsaturated fatty acid measurement (EFO:0005680) |
PMID:36764567 |
GWAS685586_H | GCST90277281 | Phosphatidylcholine (16:0_18:1) levels | 7,174 Finnish ancestry individuals | A | 0.426559 | 6E-9 | 8.222 | rs1532085 | 0.0977538 | PMID:37907536 | |
None Available | GCST90277269 | Phosphatidylethanolamine (18:0_0:0) levels | 6,258 Finnish ancestry individuals | A | 0.426559 | 2E-8 | 7.699 | rs1532085 | 0.101106 | PMID:37907536 | |
GWAS686726_H | GCST90269552 | Saturated fatty acids to total fatty acids percentage (UKB data field 23455) | 88,268 European ancestry individuals | A | 0.38604 | 3E-25 | 24.523 | rs1532085 | 0.0495442 | saturated fatty acids to total fatty acids percentage (EFO:0022305) |
PMID:36764567 |
GWAS687371_H | GCST90277331 | Phosphatidylcholine (O-16:2_18:0) levels | 6,672 Finnish ancestry individuals | A | 0.426559 | 1E-23 | 23 | rs1532085 | 0.174443 | PMID:37907536 | |
GWAS687410_H | GCST90277371 | Sphingomyelin (d34:2) levels | 7,174 Finnish ancestry individuals | A | 0.426559 | 8E-11 | 10.097 | rs1532085 | 0.109151 | PMID:37907536 | |
GWAS688130_H | GCST001639 | Metabolite levels | 6,608 European ancestry individuals | ? | 0.44 | 9E-104 | 103.046 | rs1532085 | N/A | coronary artery calcification (EFO:0004723) |
PMID:22916037 |
None Available | GCST90277327 | Phosphatidylcholine (O-16:1_18:1) levels | 7,154 Finnish ancestry individuals | A | 0.426559 | 2E-8 | 7.699 | rs1532085 | 0.0951275 | PMID:37907536 | |
GWAS691170_H | GCST90277328 | Phosphatidylcholine (O-16:1_18:2) levels | 7,096 Finnish ancestry individuals | A | 0.426559 | 9E-12 | 11.046 | rs1532085 | 0.115334 | PMID:37907536 | |
GWAS699205_H | GCST009391 | Metabolite levels | 2,076 European ancestry individuals | ? | NR | 4E-12 | 11.398 | rs1532085 | 0.24211231 | lysophosphatidylethanolamine 16:0 measurement (EFO:0010366) |
PMID:23823483 |
None Available | GCST002216 | Triglycerides | 94,595 European ancestry individuals | A | 0.40 | 2E-18 | 17.699 | rs1532085 | 0.031 | triglyceride measurement (EFO:0004530) |
PMID:24097068 |
GWAS700391_H | GCST002223 | HDL cholesterol | 94,595 European ancestry individuals | A | 0.4 | 1E-188 | 188 | rs1532085 | 0.107 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:24097068 |
GWAS700538_H | GCST001436 | Metabolic syndrome | 2,637 European ancestry cases, 7,927 European ancestry controls | G | 0.57 | 5E-24 | 23.302 | rs1532085 | 0.13 | metabolic syndrome (EFO:0000195) |
PMID:22399527 |
GWAS701343_H | GCST002221 | Cholesterol, total | 94,595 European ancestry individuals | A | 0.40 | 7E-47 | 46.155 | rs1532085 | 0.054 | total cholesterol measurement (EFO:0004574) |
PMID:24097068 |
GWAS703710_H | GCST009918 | HDL cholesterol levels | 12,685 Chinese ancestry individuals | G | 0.544 | 6E-16 | 15.222 | rs1532085 | 0.104 | HDL cholesterol change measurement (EFO:0007805) |
PMID:26690388 |
None Available | GCST90244230 | Phosphatidylcholine (16:0_16:0) levels | 2,624 European ancestry men | A | NR | 6E-9 | 8.222 | rs1532085 | 0.164469 | PMID:36193934 | |
GWAS705577_H | GCST90244284 | Phosphatidylcholine (O-16:2_18:0) levels | 2,624 European ancestry men | A | NR | 4E-11 | 10.398 | rs1532085 | 0.193022 | PMID:36193934 | |
GWAS706407_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 1E-7 | 7 | rs1532085 | 0.07799091 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS706419_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-7 | 6.699 | rs1532085 | 0.07733865 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
None Available | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-7 | 6.699 | rs1532085 | 0.076431885 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS707484_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 3E-14 | 13.523 | rs1532085 | 0.09308377 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
None Available | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-13 | 12.699 | rs1532085 | 0.10960441 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS707826_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 7E-13 | 12.155 | rs1532085 | 0.08955071 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
None Available | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 7E-13 | 12.155 | rs1532085 | 0.105751224 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
None Available | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 1E-12 | 12 | rs1532085 | 0.10512086 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS708359_H | GCST009777 | C-reactive protein levels | 418,642 British ancestry individuals | A | 0.386461 | 3E-13 | 12.523 | rs1532085 | 0.0149827 | C-reactive protein measurement (EFO:0004458) |
PMID:31900758 |
GWAS708833_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 3E-42 | 41.523 | rs1532085 | 0.16935521 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS708834_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 4E-32 | 31.398 | rs1532085 | 0.14359534 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS708838_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 4E-25 | 24.398 | rs1532085 | 0.13007617 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS708839_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-24 | 23.699 | rs1532085 | 0.1499714 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS708844_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 3E-23 | 22.523 | rs1532085 | 0.14599411 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS708846_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-22 | 21.699 | rs1532085 | 0.120991126 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS710376_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 0.000005 | 5.302 | rs1532085 | 0.06735248 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS722622_H | GCST90270119 | Multi-trait sum score | 141,980 European ancestry males | ? | NR | 4E-44 | 43.398 | rs1532085 | N/A | complex trait (EFO:0010578) |
PMID:37277458 |
GWAS723017_H | GCST90269680 | Triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23583) | 85,701 European ancestry individuals | A | 0.384943 | 2E-124 | 123.699 | rs1532085 | 0.116103 | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (EFO:0022328) |
PMID:36764567 |
GWAS723591_H | GCST90269677 | Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580) | 85,701 European ancestry individuals | A | 0.384943 | 8E-91 | 90.097 | rs1532085 | 0.0984173 | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (EFO:0022232) |
PMID:36764567 |
GWAS725090_H | GCST90269678 | Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581) | 85,701 European ancestry individuals | A | 0.384943 | 3E-66 | 65.523 | rs1532085 | 0.0842016 | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (EFO:0022246) |
PMID:36764567 |
GWAS725117_H | GCST90269681 | Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) | 87,620 European ancestry individuals | A | 0.385682 | 3E-55 | 54.523 | rs1532085 | 0.0757268 | phospholipids:total lipids ratio (EFO:0020946) |
PMID:36764567 |
GWAS725638_H | GCST90269679 | Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582) | 85,701 European ancestry individuals | A | 0.384943 | 1E-114 | 114 | rs1532085 | 0.109955 | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (EFO:0022277) |
PMID:36764567 |
GWAS726170_H | GCST90269676 | Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579) | 85,701 European ancestry individuals | A | 0.384943 | 3E-152 | 151.523 | rs1532085 | 0.127647 | phospholipids:total lipids ratio (EFO:0020946) |
PMID:36764567 |
None Available | GCST90244868 | 1-(1-enyl-stearoyl)-2-linoleoyl-GPE (p-18:0/18:2) levels | 14,296 European ancestry individuals | A | 0.3863 | 7E-13 | 12.155 | rs1532085 | 0.07537719 | 1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)* measurement (EFO:0020014) |
PMID:36357675 |
None Available | GCST90199780 | 1-stearoyl-GPG (18:0) levels | 6,806 European ancestry individuals | G | 0.62073 | 2E-10 | 9.699 | rs1532085 | 0.112161 | 1-stearoyl-GPG (18:0) measurement (EFO:0800228) |
PMID:36635386 |
GWAS734315_H | GCST006306 | HDL cholesterol | 1,017 Yoruban ancestry individuals, 1,765 Filipino ancestry individuals | A | 0.403 | 0.000008 | 5.097 | rs1532085 | 1.634 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29404214 |
GWAS735363_H | GCST90199791 | 1-arachidonoyl-GPE (20:4n6) levels | 8,270 European ancestry individuals | G | 0.623395 | 5E-11 | 10.302 | rs1532085 | 0.104314 | 1-arachidonoyl-GPE (20:4n6) measurement (EFO:0800248) |
PMID:36635386 |
None Available | GCST90269695 | Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598) | 88,329 European ancestry individuals | A | 0.386011 | 1E-36 | 36 | rs1532085 | 0.0583281 | triglycerides to total lipids in medium VLDL percentage (EFO:0022335) |
PMID:36764567 |
GWAS740864_H | GCST90200054 | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels | 8,257 European ancestry individuals | G | 0.623104 | 1E-145 | 145 | rs1532085 | 0.394729 | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement (EFO:0800409) |
PMID:36635386 |
GWAS741114_H | GCST90200079 | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) levels | 8,121 European ancestry individuals | G | 0.62153 | 3E-116 | 115.523 | rs1532085 | 0.358021 | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement (EFO:0800470) |
PMID:36635386 |
GWAS743253_H | GCST90269733 | Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636) | 88,329 European ancestry individuals | A | 0.386011 | 8E-16 | 15.097 | rs1532085 | 0.0375237 | cholesteryl esters to total lipids in large HDL percentage (EFO:0022248) |
PMID:36764567 |
GWAS743517_H | GCST90200045 | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels | 8,259 European ancestry individuals | G | 0.623195 | 4E-115 | 114.398 | rs1532085 | 0.351719 | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement (EFO:0800403) |
PMID:36635386 |
GWAS745069_H | GCST90269689 | Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592) | 88,321 European ancestry individuals | A | 0.386012 | 2E-79 | 78.699 | rs1532085 | 0.0909031 | free cholesterol to total lipids in large VLDL percentage (EFO:0022281) |
PMID:36764567 |
GWAS745441_H | GCST90269688 | Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591) | 88,321 European ancestry individuals | A | 0.386012 | 5E-133 | 132.302 | rs1532085 | 0.114371 | cholesteryl esters to total lipids in large VLDL percentage (EFO:0022250) |
PMID:36764567 |
GWAS746394_H | GCST90269691 | Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594) | 88,329 European ancestry individuals | A | 0.386011 | 2E-107 | 106.699 | rs1532085 | 0.102972 | phospholipids:total lipids ratio (EFO:0020946) |
PMID:36764567 |
GWAS747639_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | 0.378 | 2E-20 | 19.699 | rs1532085 | 0.044 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
None Available | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | 0.49 | 7E-10 | 9.155 | rs1532085 | 0.097 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS747793_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | NR | 2E-27 | 26.699 | rs1532085 | 0.046 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
None Available | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | 0.378 | 8E-12 | 11.097 | rs1532085 | 0.029 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS747950_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | 0.49 | 8E-9 | 8.097 | rs1532085 | 0.083 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS747951_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | A | NR | 2E-19 | 18.699 | rs1532085 | 0.035 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS764192_H | GCST008685 | HDL cholesterol levels | up to 23,761 African ancestry individuals, 13,171 Asian ancestry individuals, up to 90,272 European ancestry individuals, 6,620 Hispanic individuals | A | 0.4113 | 1E-65 | 65 | rs1532085 | 0.0185 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:30926973 |
GWAS776585_H | GCST90270117 | Multi-trait sum score | 161,906 European ancestry females | ? | NR | 2E-39 | 38.699 | rs1532085 | N/A | complex trait (EFO:0010578) |
PMID:37277458 |
GWAS782274_H | GCST90302129 | Cholesteryl esters to total lipids ratio in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | A | 0.408 | 3E-244 | 243.523 | rs1532085 | 0.1333 | cholesteryl esters:total lipids ratio (EFO:0020944) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS792586_H | GCST90302149 | Triglycerides to total lipids ratio in very large VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 110,896 European ancestry individuals | A | 0.4111 | 6E-61 | 60.222 | rs1532085 | 0.0726 | triglycerides:total lipids ratio (EFO:0020947) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:38448586 |
GWAS813795_H | GCST90060689 | Phosphatidylethanolamine(36:4)_[M-H]1- levels | 5,662 Pakistani ancestry individuals | A | NR | 6E-24 | 23.222 | rs1532085 | 0.1172 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
None Available | GCST90060690 | Phosphatidylethanolamine(36:4)_[M+H]1+ levels | 5,662 Pakistani ancestry individuals | C | NR | 6E-24 | 23.222 | rs1532085 | 0.0523 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
GWAS815126_H | GCST90060733 | Phosphatidylethanolamine(38:5)_[M-H]1- levels | 5,662 Pakistani ancestry individuals | A | NR | 7E-24 | 23.155 | rs1532085 | 0.0722 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
GWAS817008_H | GCST90010825 | Phosphatidylcholine acyl-alkyl C34:1 levels | 16,838 Caucasian ancestry individuals | A | 0.3768 | 3E-12 | 11.523 | rs1532085 | 6.967 | phosphatidylcholine measurement (EFO:0010226) |
PMID:33414548 |
GWAS817531_H | GCST90060315 | Phosphatidylethanolamine_38:4_[M-H]1- levels | 13,814 British ancestry individuals | A | NR | 3E-15 | 14.523 | rs1532085 | 0.0666864 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
GWAS818127_H | GCST90060274 | Phosphatidylethanolamine_36:3_[M-H]1- levels | 13,814 British ancestry individuals | A | NR | 6E-20 | 19.222 | rs1532085 | 0.0962101 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
GWAS818959_H | GCST90060272 | Phosphatidylethanolamine_36:4_[M-H]1- levels | 13,814 British ancestry individuals | A | NR | 9E-86 | 85.046 | rs1532085 | 0.228901 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
None Available | GCST90060665 | Phosphatidylethanolamine(34:2)_[M+H]1+ levels | 5,662 Pakistani ancestry individuals | A | NR | 6E-24 | 23.222 | rs1532085 | 0.103 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
GWAS819474_H | GCST90060199 | Diacylglycerol_38:6_[M+H-H2O]1+ levels | 13,814 British ancestry individuals | A | NR | 7E-21 | 20.155 | rs1532085 | 0.0954561 | diglyceride measurement (EFO:0010223) |
PMID:34503513 |
None Available | GCST90060200 | Diacylglycerol_38:5_[M+H-H2O]1+ levels | 13,814 British ancestry individuals | A | NR | 1E-12 | 12 | rs1532085 | 0.0598281 | diacylglycerol 38:5 measurement (EFO:0020067) |
PMID:34503513 |
None Available | GCST90060777 | Phosphatidylethanolamine(40:7)_[M-H]1- levels | 5,662 Pakistani ancestry individuals | A | NR | 7E-24 | 23.155 | rs1532085 | 0.0795 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
None Available | GCST90060790 | Phosphatidylcholine(37:6)_[M+H]1+/Phosphatidylethanolamine(40:6)_[M+H]1+/Phosphatidate(42:7)_[M+NH4]1+ levels | 5,662 Pakistani ancestry individuals | A | NR | 6E-24 | 23.222 | rs1532085 | 0.0938 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
GWAS824865_H | GCST90060313 | Phosphatidylethanolamine_38:5_[M-H]1- levels | 13,814 British ancestry individuals | A | NR | 3E-27 | 26.523 | rs1532085 | 0.109679 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
GWAS824884_H | GCST90060310 | Phosphatidylethanolamine_38:6_[M-H]1- levels | 13,814 British ancestry individuals | A | NR | 9E-100 | 99.046 | rs1532085 | 0.250514 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
None Available | GCST90140946 | HDL cholesterol levels | 22,000 Pakistani and Bangladeshi ancestry individuals | G | 0.46 | 6E-11 | 10.222 | rs1532085 | 0.07 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35945198 |
GWAS831959_H | GCST90092871 | Cholesteryl esters to total lipids ratio in large VLDL | 115,071 European ancestry individuals | A | 0.386036 | 9E-171 | 170.046 | rs1532085 | 0.113009 | very low density lipoprotein cholesterol measurement (EFO:0008317) cholesteryl esters:total lipids ratio (EFO:0020944) |
PMID:35213538 |
GWAS832865_H | GCST90092869 | Cholesterol to total lipids ratio in large VLDL | 115,071 European ancestry individuals | A | 0.386036 | 2E-168 | 167.699 | rs1532085 | 0.114602 | very low density lipoprotein cholesterol measurement (EFO:0008317) cholesterol:total lipids ratio (EFO:0020943) |
PMID:35213538 |
GWAS840062_H | GCST90060249 | Phosphatidylcholine_31:2_[M+H]1+/Phosphatidylethanolamine_34:2_[M+H]1+/Phosphatidate_36:3_[M+NH4]1+ levels | 13,814 British ancestry individuals | A | NR | 5E-75 | 74.302 | rs1532085 | 0.225862 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
None Available | GCST90060699 | Phosphatidate(39:1)_[M+H]1+ levels | 5,662 Pakistani ancestry individuals | T | NR | 7E-24 | 23.155 | rs1532085 | 0.0602 | phosphatidate measurement (EFO:0020047) |
PMID:34503513 |
GWAS841049_H | GCST90060316 | Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+NH4]1+ levels | 13,814 British ancestry individuals | A | NR | 4E-106 | 105.398 | rs1532085 | 0.256735 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
GWAS842091_H | GCST90060273 | Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels | 13,814 British ancestry individuals | A | NR | 6E-112 | 111.222 | rs1532085 | 0.270885 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
None Available | GCST90060319 | Phosphatidylcholine_35:3_[M+H]1+/Phosphatidylethanolamine_38:3_[M+H]1+/Phosphatidate_40:4_[M+NH4]1+ levels | 13,814 British ancestry individuals | A | NR | 4E-12 | 11.398 | rs1532085 | 0.0712708 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
None Available | GCST90060137 | Lysophosphatidylethanolamine_16:0_[M-H]1- levels | 13,814 British ancestry individuals | A | NR | 1E-12 | 12 | rs1532085 | 0.07781 | lysophosphatidylethanolamine measurement (EFO:0010225) |
PMID:34503513 |
GWAS851319_H | GCST90060371 | Phosphatidylcholine_37:6_[M+H]1+/Phosphatidylethanolamine_40:6_[M+H]1+/Phosphatidate_42:7_[M+NH4]1+ levels | 13,814 British ancestry individuals | A | NR | 1E-39 | 39 | rs1532085 | 0.194144 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
GWAS860200_H | GCST012232 | Lipoprotein (a) levels | 348,591 European ancestry individuals, 6,000 African ancestry individuals, 9,116 Asian ancestry individuals, 7,505 individuals | A | NR | 9E-10 | 9.046 | rs1532085 | 0.008666 | lipoprotein A measurement (EFO:0006925) |
PMID:33730874 |
None Available | GCST90060692 | Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+NH4]1+ levels | 5,662 Pakistani ancestry individuals | G | NR | 6E-24 | 23.222 | rs1532085 | 0.0777 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
None Available | GCST90060738 | Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+NH4]1+ levels | 5,662 Pakistani ancestry individuals | T | NR | 6E-24 | 23.222 | rs1532085 | 0.0694 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
None Available | GCST90060696 | Phosphatidylcholine(33:2)_[M+H]1+/Phosphatidylethanolamine(36:2)_[M+H]1+/Phosphatidate(38:3)_[M+NH4]1+ levels | 5,662 Pakistani ancestry individuals | T | NR | 6E-24 | 23.222 | rs1532085 | 0.1429 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
GWAS890687_H | GCST90092817 | Ratio of docosahexaenoic acid to total fatty acid levels | 115,006 European ancestry individuals | A | 0.386032 | 1E-45 | 45 | rs1532085 | 0.0581405 | docosahexaenoic acid measurement (EFO:0007761) fatty acid measurement (EFO:0005110) |
PMID:35213538 |
None Available | GCST90060250 | Phosphatidylethanolamine_34:1_[M-H]1- levels | 13,814 British ancestry individuals | A | NR | 2E-15 | 14.699 | rs1532085 | 0.0827329 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
GWAS891306_H | GCST90060247 | Phosphatidylethanolamine_34:2_[M-H]1- levels | 13,814 British ancestry individuals | A | NR | 5E-47 | 46.302 | rs1532085 | 0.168228 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:34503513 |
GWAS895111_H | GCST90060312 | Phosphatidylcholine_35:6_[M+H]1+/Phosphatidylethanolamine_38:6_[M+H]1+/Phosphatidate_40:7_[M+NH4]1+ levels | 13,814 British ancestry individuals | A | NR | 7E-93 | 92.155 | rs1532085 | 0.253177 | phosphatidylcholine measurement (EFO:0010226) |
PMID:34503513 |
None Available | GCST90020244 | Vitamin D insufficiency | 35,079 European ancestry cases, 140,898 European ancestry controls | A | 0.383 | 1E-8 | 8 | rs1532085 | 0.05 | vitamin D deficiency (EFO:0003762) |
PMID:34308111 |
GWAS905654_H | GCST90092932 | Ratio of omega-3 fatty acids to total fatty acids | 115,006 European ancestry individuals | A | 0.386032 | 3E-82 | 81.523 | rs1532085 | 0.078198 | fatty acid measurement (EFO:0005110) |
PMID:35213538 |
GWAS905885_H | GCST90092934 | Ratio of omega-6 fatty acids to omega-3 fatty acids | 115,006 European ancestry individuals | A | 0.386032 | 3E-99 | 98.523 | rs1532085 | 0.0862885 | fatty acid measurement (EFO:0005110) |
PMID:35213538 |
GWAS915626_H | GCST90090989 | High density lipoprotein cholesterol levels | 17,641 African American individuals, 22,830 Hispanics ancestry individuals, 2,378 East Asian ancestry individuals, 1,912 Native Hawaiian ancestry individuals, 604 Native American ancestry individuals, 333 individuals, 22,887 European ancestry individuals | ? | NR | 6E-25 | 24.222 | rs1532085 | 0.082 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:32226016 |
GWAS916503_H | GCST90029070 | C-reactive protein levels | 575,531 European ancestry individuals | A | NR | 5E-13 | 12.302 | rs1532085 | 0.0147 | C-reactive protein measurement (EFO:0004458) |
PMID:35459240 |
GWAS927823_H | GCST90132636 | Triglyceride levels in very large HDL | 21,536 European ancestry individuals | G | 0.6 | 9E-155 | 154.046 | rs1532085 | 0.26 | triglyceride measurement (EFO:0004530) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:27005778 |
None Available | GCST90024366 | Phosphatidylethanolamine (18:0_18:2) levels | 4,492 European ancestry individuals | G | NR | 4E-44 | 43.398 | rs1532085 | 0.314 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS940667_H | GCST90024371 | Phosphatidylethanolamine (18:0_22:5) (n3) levels | 4,492 European ancestry individuals | G | NR | 1E-47 | 47 | rs1532085 | 0.325 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS940955_H | GCST90024354 | Phosphatidylethanolamine (16:0_18:3) (b) levels | 4,492 European ancestry individuals | G | NR | 3E-34 | 33.523 | rs1532085 | 0.272 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
None Available | GCST90024355 | Phosphatidylethanolamine (16:0_20:3) levels | 4,492 European ancestry individuals | G | NR | 1E-36 | 36 | rs1532085 | 0.286 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS942492_H | GCST90024359 | Phosphatidylethanolamine (16:1_18:2) levels | 4,492 European ancestry individuals | G | NR | 4E-13 | 12.398 | rs1532085 | 0.163 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS957204_H | GCST90093045 | Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | 111,638 European ancestry individuals | A | 0.384918 | 2E-144 | 143.699 | rs1532085 | 0.108126 | chylomicron measurement (EFO:0008596) very low density lipoprotein cholesterol measurement (EFO:0008317) free cholesterol:total lipids ratio (EFO:0020945) |
PMID:35213538 |
GWAS957468_H | GCST90093051 | Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL | 111,638 European ancestry individuals | A | 0.384918 | 2E-155 | 154.699 | rs1532085 | 0.113642 | chylomicron measurement (EFO:0008596) triglycerides:total lipids ratio (EFO:0020947) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:35213538 |
GWAS957779_H | GCST90093043 | Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL | 111,638 European ancestry individuals | A | 0.384918 | 8E-81 | 80.097 | rs1532085 | 0.0814245 | chylomicron measurement (EFO:0008596) very low density lipoprotein cholesterol measurement (EFO:0008317) cholesteryl esters:total lipids ratio (EFO:0020944) |
PMID:35213538 |
GWAS965146_H | GCST90024600 | Total Phosphatidylglycerol levels | 4,492 European ancestry individuals | G | NR | 9E-27 | 26.046 | rs1532085 | 0.241 | glycerophospholipid measurement (EFO:0007630) |
PMID:35668104 |
None Available | GCST90024450 | Phosphatidylglycerol (34:2) levels | 4,492 European ancestry individuals | G | NR | 2E-15 | 14.699 | rs1532085 | 0.176 | glycerophospholipid measurement (EFO:0007630) |
PMID:35668104 |
GWAS965832_H | GCST90024452 | Phosphatidylglycerol (36:2) levels | 4,492 European ancestry individuals | G | NR | 3E-18 | 17.523 | rs1532085 | 0.195 | glycerophospholipid measurement (EFO:0007630) |
PMID:35668104 |
None Available | GCST90024346 | Phosphatidylethanolamine (15-MHDA_18:2) levels | 4,492 European ancestry individuals | G | NR | 9E-32 | 31.046 | rs1532085 | 0.264 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS967702_H | GCST90024347 | Phosphatidylethanolamine (15-MHDA_20:4) levels | 4,492 European ancestry individuals | G | NR | 3E-30 | 29.523 | rs1532085 | 0.256 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS967708_H | GCST90024349 | Phosphatidylethanolamine (16:0_16:0) levels | 4,492 European ancestry individuals | G | NR | 1E-18 | 18 | rs1532085 | 0.196 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
None Available | GCST90025585 | Phosphatidylethanolamine (15-MHDA_18:2) levels | 4,492 European ancestry individuals | G | NR | 8E-41 | 40.097 | rs1532085 | 0.301 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS967974_H | GCST90025586 | Phosphatidylethanolamine (15-MHDA_20:4) levels | 4,492 European ancestry individuals | G | NR | 2E-41 | 40.699 | rs1532085 | 0.302 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
None Available | GCST90025588 | Phosphatidylethanolamine (16:0_16:0) levels | 4,492 European ancestry individuals | G | NR | 4E-25 | 24.398 | rs1532085 | 0.231 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS967976_H | GCST90025591 | Phosphatidylethanolamine (16:0_18:2) levels | 4,492 European ancestry individuals | G | NR | 7E-45 | 44.155 | rs1532085 | 0.316 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS968633_H | GCST90024449 | Phosphatidylglycerol (34:1) levels | 4,492 European ancestry individuals | G | NR | 4E-20 | 19.398 | rs1532085 | 0.206 | glycerophospholipid measurement (EFO:0007630) |
PMID:35668104 |
None Available | GCST90239609 | Total cholesterol levels | 76,578 Taiwanese ancestry individuals | ? | NR | 3E-34 | 33.523 | rs1532085 | 2.10538 | total cholesterol measurement (EFO:0004574) |
PMID:36329257 |
None Available | GCST90024352 | Phosphatidylethanolamine (16:0_18:2) levels | 4,492 European ancestry individuals | G | NR | 3E-38 | 37.523 | rs1532085 | 0.292 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS970041_H | GCST90025605 | Phosphatidylethanolamine (18:0_18:2) levels | 4,492 European ancestry individuals | G | NR | 4E-41 | 40.398 | rs1532085 | 0.303 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS970044_H | GCST90025610 | Phosphatidylethanolamine (18:0_22:5) (n3) levels | 4,492 European ancestry individuals | G | NR | 8E-42 | 41.097 | rs1532085 | 0.306 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS970067_H | GCST90025688 | Phosphatidylglycerol (34:1) levels | 4,492 European ancestry individuals | G | NR | 1E-26 | 26 | rs1532085 | 0.241 | glycerophospholipid measurement (EFO:0007630) |
PMID:35668104 |
GWAS970068_H | GCST90025689 | Phosphatidylglycerol (34:2) levels | 4,492 European ancestry individuals | G | NR | 7E-16 | 15.155 | rs1532085 | 0.181 | glycerophospholipid measurement (EFO:0007630) |
PMID:35668104 |
None Available | GCST90025593 | Phosphatidylethanolamine (16:0_18:3) (b) levels | 4,492 European ancestry individuals | G | NR | 2E-39 | 38.699 | rs1532085 | 0.294 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS970289_H | GCST90025594 | Phosphatidylethanolamine (16:0_20:3) levels | 4,492 European ancestry individuals | G | NR | 1E-41 | 41 | rs1532085 | 0.305 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
None Available | GCST90025598 | Phosphatidylethanolamine (16:1_18:2) levels | 4,492 European ancestry individuals | G | NR | 2E-24 | 23.699 | rs1532085 | 0.23 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
None Available | GCST90179149 | Triglyceride levels (MTAG) | 361,194 European ancestry individuals | A | NR | 5E-11 | 10.302 | rs1532085 | 0.016721 | triglyceride measurement (EFO:0004530) |
PMID:36376304 |
GWAS976911_H | GCST90092994 | Degree of unsaturation | 115,006 European ancestry individuals | A | 0.386032 | 4E-22 | 21.398 | rs1532085 | 0.0389563 | fatty acid measurement (EFO:0005110) |
PMID:35213538 |
GWAS977761_H | GCST90239613 | Very low density lipoprotein cholesterol levels | 75,388 Taiwanese ancestry individuals | ? | NR | 2E-78 | 77.699 | rs1532085 | 1.37233 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:36329257 |
GWAS979126_H | GCST90239610 | Triglyceride levels | 76,053 Taiwanese ancestry individuals | ? | NR | 7E-18 | 17.155 | rs1532085 | 2.71526 | triglyceride measurement (EFO:0004530) |
PMID:36329257 |
None Available | GCST90444489 | Metabolic syndrome | 10,684 Korean ancestry cases, 51,630 Korean ancestry controls | ? | NR | 2E-8 | 7.699 | rs1532085 | 0.0856822 | metabolic syndrome (EFO:0000195) |
PMID:39349817 |
GWAS981390_H | GCST90025207 | Total Phosphatidylethanolamine levels | 6,057 European ancestry individuals | G | NR | 2E-82 | 81.699 | rs1532085 | N/A | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS988846_H | GCST90093041 | Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | 111,638 European ancestry individuals | A | 0.384918 | 7E-113 | 112.155 | rs1532085 | 0.0960421 | chylomicron measurement (EFO:0008596) very low density lipoprotein cholesterol measurement (EFO:0008317) cholesterol:total lipids ratio (EFO:0020943) |
PMID:35213538 |
RGD Curation Notes
Note Type | Note | Reference |
---|